GON SA EZETI-10
Primary Hypercholesterolaemia: Ezetimibe co-administered with an HMG-CoA reductase inhibitor (statin) is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial…GUARENTE-16
[pdf-embedder url="https://davipharm.info/wp-content/uploads/GUARENTE_01.pdf"]GUARENTE-8
[pdf-embedder url="https://davipharm.info/wp-content/uploads/GUARENTE-8_0390.T1.pdf"]GYGARIL-5
[pdf-embedder url="https://davipharm.info/wp-content/uploads/GYGARIL-5-0125.T1.pdf"]HATLOP-150
[pdf-embedder url="https://davipharm.info/wp-content/uploads/HATLOP-300-0042.T1.pdf"]HATLOP-300
[pdf-embedder url="https://davipharm.info/wp-content/uploads/HATLOP-300-0042.T1-1.pdf"]HUNTELAAR-2
Lacidipine is indicated in adults for the treatment of hypertension either alone or in combination with other antihypertensive agents, including ß-adrenoceptor antagonists, diuretics, and ACE-inhibitors…ISAIAS
[pdf-embedder url="https://davipharm.info/wp-content/uploads/ISAIAS_01.pdf"]KHOUMA
[pdf-embedder url="https://davipharm.info/wp-content/uploads/KHOUMA_02.pdf"]LAVEZZI-10
[pdf-embedder url="https://davipharm.info/wp-content/uploads/LAVEZZI-10_0404.T1.pdf"]LAVEZZI-5
[pdf-embedder url="https://davipharm.info/wp-content/uploads/LAVEZZI-5_0394.T1.pdf"]METAZREL
[pdf-embedder url="https://davipharm.info/wp-content/uploads/METAZREL-0181.T1.pdf"]
Davipharm
